John Montana
Saffron Walden, England, United Kingdom
2K followers
500+ connections
Saffron Walden, England, United Kingdom
2K followers
500+ connections
Activity
-
Today is Gannet be the day that they're gonna throw it back to you
Today is Gannet be the day that they're gonna throw it back to you
Liked by John Montana
-
Metrion’s human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte assay is an advanced tool, providing key advantages, for early cardiac…
Metrion’s human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte assay is an advanced tool, providing key advantages, for early cardiac…
Liked by John Montana
-
We are pleased to announce that our via our Forbion Growth Opportunities Fund II, we have co-led a $100M Series A financing round for Navigator…
We are pleased to announce that our via our Forbion Growth Opportunities Fund II, we have co-led a $100M Series A financing round for Navigator…
Liked by John Montana
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Licenses & Certifications
-
Bsc Hons, PhD
-
Patents
-
Indolizine derivates with CRTH2 receptor affinity for the treatment of inflammatory disease
Issued EU WO2009044147
Other inventors -
Organizations
-
Royal Society of Chemistry
-
- Present
More activity by John
-
We are excited to share that River BioMedics B.V. has been recognized as Key Innovator by the EU's Innovation Radar for our work on the EU-funded…
We are excited to share that River BioMedics B.V. has been recognized as Key Innovator by the EU's Innovation Radar for our work on the EU-funded…
Liked by John Montana
-
From American Society for Preventive Cardiology (ASPC): “Lower [LDL-C] for longer is better, and achieving very low LDL-C is feasible and safe.”…
From American Society for Preventive Cardiology (ASPC): “Lower [LDL-C] for longer is better, and achieving very low LDL-C is feasible and safe.”…
Liked by John Montana
-
The DisPATCHes newsletter delivers the latest ion channel, cardiac safety and neuroscience news from Metrion Biosciences. Subscribe to DisPATCHes to…
The DisPATCHes newsletter delivers the latest ion channel, cardiac safety and neuroscience news from Metrion Biosciences. Subscribe to DisPATCHes to…
Liked by John Montana
-
A meta-analysis published in The Lancet found high-intensity statins were more likely to increase glycemia compared to low- or moderate-intensity…
A meta-analysis published in The Lancet found high-intensity statins were more likely to increase glycemia compared to low- or moderate-intensity…
Liked by John Montana
-
On 𝟭𝟴𝘁𝗵 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 we invite you to the webinar '𝗥𝗲𝗰𝗲𝗻𝘁 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗧𝗼𝘄𝗮𝗿𝗱𝘀 𝗮 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁…
On 𝟭𝟴𝘁𝗵 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 we invite you to the webinar '𝗥𝗲𝗰𝗲𝗻𝘁 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗧𝗼𝘄𝗮𝗿𝗱𝘀 𝗮 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁…
Liked by John Montana
-
We recently carried out our 500th balloon pulmonary angioplasty (BPA), a pioneering procedure for patients with a rare form of pulmonary…
We recently carried out our 500th balloon pulmonary angioplasty (BPA), a pioneering procedure for patients with a rare form of pulmonary…
Liked by John Montana
-
The #SLEIMPN meeting is one of the largest conferences on metabolic diseases and neonatal screening in South America. This year it will be held in…
The #SLEIMPN meeting is one of the largest conferences on metabolic diseases and neonatal screening in South America. This year it will be held in…
Liked by John Montana
-
A new Nature Reviews Cardiology publication reinforces the growing consensus that with LDL-C, “lower is better, and earlier is better,” suggesting…
A new Nature Reviews Cardiology publication reinforces the growing consensus that with LDL-C, “lower is better, and earlier is better,” suggesting…
Liked by John Montana
-
Next week Steve Jenkinson is attending the Sophion Annual North America User Meeting where he looks forward to discussions on automated patch-clamp…
Next week Steve Jenkinson is attending the Sophion Annual North America User Meeting where he looks forward to discussions on automated patch-clamp…
Liked by John Montana
-
Congratulations to our portfolio company, Noema Pharma, on this achievement - great news 🎉
Congratulations to our portfolio company, Noema Pharma, on this achievement - great news 🎉
Liked by John Montana
-
We’re pleased to share some of our recent accomplishments, corporate updates, and financial results for the second quarter and first half of 2024…
We’re pleased to share some of our recent accomplishments, corporate updates, and financial results for the second quarter and first half of 2024…
Liked by John Montana
-
We show the optimisation of TREK-1 parameters for dual screening of agonist and antagonist activity using a QPatch48. (A) The effect of increasing…
We show the optimisation of TREK-1 parameters for dual screening of agonist and antagonist activity using a QPatch48. (A) The effect of increasing…
Liked by John Montana
-
This time of year again we will be reviewing applications for our Medicinal Chemistry Workshop 2024 by the end of August a great day for students to…
This time of year again we will be reviewing applications for our Medicinal Chemistry Workshop 2024 by the end of August a great day for students to…
Liked by John Montana
-
At last year's TED AI, Aviv Regev, our Head of Genentech Research and Early Development, gave a talk on the impact of artificial intelligence on drug…
At last year's TED AI, Aviv Regev, our Head of Genentech Research and Early Development, gave a talk on the impact of artificial intelligence on drug…
Liked by John Montana
-
🏥💊 Tackling Obesity with Innovation! Join us for the 'Investing in NextGen Obesity Drugs Panel' at the #Sachs_BEF on September 25th, 2024, at the…
🏥💊 Tackling Obesity with Innovation! Join us for the 'Investing in NextGen Obesity Drugs Panel' at the #Sachs_BEF on September 25th, 2024, at the…
Liked by John Montana
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named John Montana
-
John Montana
-
John Montaña
Principal at the Montaña Group
-
John Montana
Quantum Computing, Quantum Production, Quantum Energy, Quantum Engineering and Applications
-
John Montana
Director, Global Commercial Planning, Pfizer Hospital
121 others named John Montana are on LinkedIn
See others named John Montana